Veru Inc. (NASDAQ:VERU) Shares Bought by State Street Corp

State Street Corp grew its position in Veru Inc. (NASDAQ:VERU) by 4.3% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,072,065 shares of the company’s stock after buying an additional 84,483 shares during the quarter. State Street Corp owned 1.42% of Veru worth $1,593,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Gladstone Institutional Advisory LLC lifted its position in shares of Veru by 34.2% in the third quarter. Gladstone Institutional Advisory LLC now owns 56,876 shares of the company’s stock valued at $44,000 after acquiring an additional 14,500 shares in the last quarter. Blair William & Co. IL raised its stake in Veru by 6.1% in the 2nd quarter. Blair William & Co. IL now owns 350,000 shares of the company’s stock valued at $294,000 after purchasing an additional 20,000 shares during the last quarter. SG Americas Securities LLC lifted its holdings in Veru by 185.9% in the 3rd quarter. SG Americas Securities LLC now owns 66,128 shares of the company’s stock valued at $51,000 after purchasing an additional 42,997 shares in the last quarter. Rhumbline Advisers lifted its holdings in Veru by 3,994.8% in the 2nd quarter. Rhumbline Advisers now owns 113,632 shares of the company’s stock valued at $96,000 after purchasing an additional 110,857 shares in the last quarter. Finally, Squarepoint Ops LLC acquired a new stake in shares of Veru during the 2nd quarter worth about $161,000. Institutional investors and hedge funds own 47.16% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have commented on VERU. Oppenheimer reaffirmed an “outperform” rating and issued a $5.00 target price on shares of Veru in a research note on Tuesday, November 5th. HC Wainwright reaffirmed a “buy” rating and issued a $3.00 price objective on shares of Veru in a research report on Friday, December 20th.

Veru Stock Performance

Shares of VERU stock opened at $0.65 on Thursday. The stock has a market capitalization of $95.22 million, a price-to-earnings ratio of -1.36 and a beta of -0.50. Veru Inc. has a one year low of $0.36 and a one year high of $1.92. The company’s 50-day simple moving average is $0.70 and its 200-day simple moving average is $0.80.

Veru (NASDAQ:VERU) last posted its quarterly earnings results on Monday, December 16th. The company reported ($0.06) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.07) by $0.01. Veru had a negative net margin of 376.38% and a negative return on equity of 115.99%. As a group, research analysts forecast that Veru Inc. will post -0.3 EPS for the current year.

Veru Profile

Veru Inc, a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). Its marketed products comprise FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections.